首页 > 最新文献

International Journal of Ayurvedic Medicine最新文献

英文 中文
Role of Withaferin A in the management of breast cancer: A comprehensive review Withaferin A在乳腺癌治疗中的作用:一项综合综述
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3687
Dhanashri Joil, Swagata Dilip Tavhare
Background: Breast cancer is one of the leading causes for cancer mortality. The conventional treatments are being rprted for many side effects which affects quality of life of a patient. Novel therapeutic and preventative strategies from the medicinal herbs are needed to reduce suffering, disease free survival, and mortality from breast cancer. Withania somnifera L. Dunal (Indian winter cherry or Ashwagandha) from the Solanaceae family is an appealing medicinal plant widely investigated for its breast cancer potential. Ayurveda treaties explained various formulations using root of Ashwagandha. Modern science explained uses of root and leaf in extract forms. Withaferin A is a promising anticancer withanolides. This review is based on in-vitro researches of Withaferin A on breast cancer cell lines like MCF-7 cells, MDA-MB-231, SUM159, MDA-MB-468, SUM149,SUM159, 231MFP supported by its mechanism, in-vivo studies and clinical records. Material and methods: This review is based on various preclinical researches related to breast cancer. Moreover, this review represents the effect of Withaferin A on cancer cell. Various articles including studies and description of Ashwagandha were reviewed using databases namely Google Scholar, PubMed, Web of Science, Scopus. Result:Withaferin A significantly arrests the growth of many breast cancer cell in vivo and in vitro. Conclusion: Ashwagandha is a commonly available, cost effective natural medicine,possess anti-cancer potential. It can serves a add on treatment strategy for breast cancer management, chemoprevention, tumor suppression.
背景:乳腺癌是导致癌症死亡的主要原因之一。据报道,传统的治疗方法有许多副作用,影响病人的生活质量。需要从草药中获得新的治疗和预防策略,以减少乳腺癌的痛苦、无病生存和死亡率。来自茄科的Withania somnifera L. Dunal(印度冬季樱桃或Ashwagandha)是一种有吸引力的药用植物,因其乳腺癌的潜力而被广泛研究。阿育吠陀条约解释了使用阿什瓦甘达根的各种配方。现代科学以提取物的形式解释了根和叶的用途。Withaferin A是一种很有前途的抗癌药物。本文综述了Withaferin A对MCF-7细胞、MDA-MB-231、SUM159、MDA-MB-468、SUM149、SUM159、231MFP等乳腺癌细胞系的体外研究,并结合其作用机制、体内研究和临床记录进行了综述。材料和方法:本综述基于各种与乳腺癌相关的临床前研究。此外,本文综述了Withaferin A对癌细胞的作用。使用Google Scholar、PubMed、Web of Science、Scopus等数据库对包括Ashwagandha研究和描述在内的各种文章进行了审查。结果:Withaferin A在体内和体外均能显著抑制多种乳腺癌细胞的生长。结论:印度人参是一种常见的、经济有效的天然药物,具有抗癌潜力。它可以作为乳腺癌管理、化学预防、肿瘤抑制的补充治疗策略。
{"title":"Role of Withaferin A in the management of breast cancer: A comprehensive review","authors":"Dhanashri Joil, Swagata Dilip Tavhare","doi":"10.47552/ijam.v14i3.3687","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3687","url":null,"abstract":"Background: Breast cancer is one of the leading causes for cancer mortality. The conventional treatments are being rprted for many side effects which affects quality of life of a patient. Novel therapeutic and preventative strategies from the medicinal herbs are needed to reduce suffering, disease free survival, and mortality from breast cancer. Withania somnifera L. Dunal (Indian winter cherry or Ashwagandha) from the Solanaceae family is an appealing medicinal plant widely investigated for its breast cancer potential. Ayurveda treaties explained various formulations using root of Ashwagandha. Modern science explained uses of root and leaf in extract forms. Withaferin A is a promising anticancer withanolides. This review is based on in-vitro researches of Withaferin A on breast cancer cell lines like MCF-7 cells, MDA-MB-231, SUM159, MDA-MB-468, SUM149,SUM159, 231MFP supported by its mechanism, in-vivo studies and clinical records. Material and methods: This review is based on various preclinical researches related to breast cancer. Moreover, this review represents the effect of Withaferin A on cancer cell. Various articles including studies and description of Ashwagandha were reviewed using databases namely Google Scholar, PubMed, Web of Science, Scopus. Result:Withaferin A significantly arrests the growth of many breast cancer cell in vivo and in vitro. Conclusion: Ashwagandha is a commonly available, cost effective natural medicine,possess anti-cancer potential. It can serves a add on treatment strategy for breast cancer management, chemoprevention, tumor suppression.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135788415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analytical study and preparation of praval garbha pottali 乌桕的分析研究与制备
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3756
Sucheta Pilankar, Arati P Dubewar, Sonali C Chitali, Nilima S Dharkar
The Pottali rasayana Kalpana is one among the four types of rejuvenation formulations (Chaturvidh rasayana Kalpana) of mercury (Parad). They are known for its specific method of preparation, unique end product, optimum potency, smaller dosage and larger therapeutic applicability. Praval garbha pottali is a herbo-mineral complex formulation. Gandhak paka method was selected for preparation as it is the most commonly used procedure. It also is a best method to enhance the efficiency of the drugs and keep them in a concise form. The description of Pottali rasayana Kalpana is found in numerous Rasagranthas (Classical books of Rasa shastra); however, very less research work is carried out on them, and minimal research is carried out on Praval garbha pottali. Pottali rasayana Kalpana are not well-versed in current ayurvedic practice due to the lack of research study. XRD, FTIR, and EDS mapping is carried out on the prepared pravalgarbha pottali.
Pottali rasayana Kalpana是汞(Parad)的四种恢复配方(Chaturvidh rasayana Kalpana)之一。它们以其特定的制备方法,独特的最终产物,最佳效力,较小的剂量和较大的治疗适用性而闻名。Praval garbha pottali是一种草药矿物复合配方。选择Gandhak paka方法作为制备方法,因为这是最常用的方法。这也是提高药物效率和保持药物简洁形式的最佳方法。Pottali rasayana Kalpana的描述可以在许多Rasagranthas (Rasa shastra的经典书籍)中找到;然而,对它们进行的研究工作很少,对Praval garbha pottali进行的研究也很少。由于缺乏研究,Pottali rasayana Kalpana并不精通当前的阿育吠陀实践。用XRD、FTIR和EDS对制备的巴伐他林进行了表征。
{"title":"Analytical study and preparation of praval garbha pottali","authors":"Sucheta Pilankar, Arati P Dubewar, Sonali C Chitali, Nilima S Dharkar","doi":"10.47552/ijam.v14i3.3756","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3756","url":null,"abstract":"The Pottali rasayana Kalpana is one among the four types of rejuvenation formulations (Chaturvidh rasayana Kalpana) of mercury (Parad). They are known for its specific method of preparation, unique end product, optimum potency, smaller dosage and larger therapeutic applicability. Praval garbha pottali is a herbo-mineral complex formulation. Gandhak paka method was selected for preparation as it is the most commonly used procedure. It also is a best method to enhance the efficiency of the drugs and keep them in a concise form. The description of Pottali rasayana Kalpana is found in numerous Rasagranthas (Classical books of Rasa shastra); however, very less research work is carried out on them, and minimal research is carried out on Praval garbha pottali. Pottali rasayana Kalpana are not well-versed in current ayurvedic practice due to the lack of research study. XRD, FTIR, and EDS mapping is carried out on the prepared pravalgarbha pottali.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Abhighatjanya Apabahuka (Traumatic Frozen shoulder) by Ayurveda: A Case study 阿育吠陀治疗外伤性肩周炎的个案研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3814
Nishant Patel, Nisha Munishwar, Prakash Kumbar
Apabahuka (Frozen shoulder-FS) is a disease that affects the shoulder joint. Frozen shoulder is also known as adhesive capsulitis, it is characterized by pain and stiffness in the shoulder joint and upper arm muscles with restricted mobility. Apabahuka is a Vataj vyadhi associated with Kapha dosha. The prevalence of FS varies from 11.4% to 19% in India. FS is commonly found between 40 to 70 years and most common in females. Various modalities are available to treat FS such as nonsteroidal anti-inflammatory drugs, corticosteroids, physiotherapy, ultrasound therapy, arthroscopic surgery, or a combination of treatments done still no satisfactory results are found. In the present case report, a 50-year-old female patient consulted with the chief complaints of pain, stiffness, restricted mobility of shoulder joint and pain while lifting weight along with disturbed sleep. Patient was diagnosed as a Abhighatjanya Apabahuka (Traumatic FS). The patient was assessed on the basis of Visual Analogue Scale (VAS), Stiffness Gradation, Tenderness Gradation and range of movements using Goniometer. Patient was treated with Panchakarma therapies and internal medication. The outcome of Ayurvedic management of FS was encouraging to reduce subjective and objective parameters.
Apabahuka(冻结肩- fs)是一种影响肩关节的疾病。冻肩又称粘连性囊炎,其特点是肩关节和上臂肌肉疼痛僵硬,活动受限。Apabahuka是与Kapha dosha相关的Vataj vyadhi。FS的患病率在印度从11.4%到19%不等。FS常见于40至70岁之间,最常见于女性。治疗FS有多种方法,如非甾体类抗炎药、皮质类固醇、物理治疗、超声治疗、关节镜手术或综合治疗,但仍未发现令人满意的结果。在本病例报告中,一名50岁女性患者就诊,主诉为疼痛、僵硬、肩关节活动受限和举重时疼痛,同时伴有睡眠障碍。诊断为创伤性FS (Abhighatjanya Apabahuka)。采用视觉模拟评分法(VAS)、僵硬评分法、压痛评分法和关节角计对患者进行评估。患者接受Panchakarma疗法和内服药物治疗。阿育吠陀治疗FS的结果令人鼓舞,减少了主观和客观参数。
{"title":"Management of Abhighatjanya Apabahuka (Traumatic Frozen shoulder) by Ayurveda: A Case study","authors":"Nishant Patel, Nisha Munishwar, Prakash Kumbar","doi":"10.47552/ijam.v14i3.3814","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3814","url":null,"abstract":"Apabahuka (Frozen shoulder-FS) is a disease that affects the shoulder joint. Frozen shoulder is also known as adhesive capsulitis, it is characterized by pain and stiffness in the shoulder joint and upper arm muscles with restricted mobility. Apabahuka is a Vataj vyadhi associated with Kapha dosha. The prevalence of FS varies from 11.4% to 19% in India. FS is commonly found between 40 to 70 years and most common in females. Various modalities are available to treat FS such as nonsteroidal anti-inflammatory drugs, corticosteroids, physiotherapy, ultrasound therapy, arthroscopic surgery, or a combination of treatments done still no satisfactory results are found. In the present case report, a 50-year-old female patient consulted with the chief complaints of pain, stiffness, restricted mobility of shoulder joint and pain while lifting weight along with disturbed sleep. Patient was diagnosed as a Abhighatjanya Apabahuka (Traumatic FS). The patient was assessed on the basis of Visual Analogue Scale (VAS), Stiffness Gradation, Tenderness Gradation and range of movements using Goniometer. Patient was treated with Panchakarma therapies and internal medication. The outcome of Ayurvedic management of FS was encouraging to reduce subjective and objective parameters.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study on the effectiveness of Pathadi churna and Protein powder in Karshya (Undernutrition) among preschool children 蛋白粉与百达果对学龄前儿童营养不良疗效的比较研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3612
Renu B Rathi, Monali Kurhadkar, Bharat J Rathi, Sandesh Khobragade, Sumod Khedekar
Introduction: Ayurveda depicts a disease named ‘Karshya’ which goes hand in hand with the clinical entity ‘Under-nutrition’ in contemporary science. Aim & Objectives: The present study aimed to compare the efficacy of ‘Pathadi churna’ and Protein Powder as oral administration in preschool children suffering from Under-nutrition. Methodology- The trial was a randomized parallel group carried out in 30 children aged 3 to 6 years presenting with the clinical features of under-nutrition who were divided into two groups equally. In Pathadi churna (group A-trial) and protein powder (control, group B), Pathadi churna and protein powder respectively was given in dosage according to age as per Young’s formula for 60 days. Results were analyzed according to frequency %, PEM (protein energy malnutrition) gradation shift, changes in assessment parameters, and the level of significance were noted by using Wilcoxon signed rank test and the Student’s paired t-test. Results- Significant results were noted in Daurabalya (~Fatigue) in both the groups whereas the Pathadi churna group showed significant results in the Agnimandya (~Lack of appetite & poor digestion), weight, weight for height, BMI, PEM gradation, and the values of hemoglobin, serum proteins & calcium. On comparing both groups, statistically significant differences were seen in Pathadi churna than Protein powder. Conclusion- Significant results were seen in Daurbalya in both the groups but on comparison more significant effects were noted for all subjective and objective criteria in the Pathadi churna group. No ADR was reported in the study. Further large sample studies with standard control would render better evidence in results with justification.
简介:阿育吠陀描述了一种名为“Karshya”的疾病,它与当代科学中的临床实体“营养不良”密切相关。的目标,目的:比较白参蛋白粉与白参蛋白粉口服治疗学龄前营养不良儿童的疗效。方法:该试验是一个随机平行组,在30名3至6岁的儿童中进行,这些儿童表现出营养不良的临床特征,他们被平均分为两组。山茱萸(a组)和蛋白粉(对照组,B组)分别按年龄按杨氏配方给予山茱萸和蛋白粉剂量,试验期60 d。采用Wilcoxon sign rank检验和Student’s配对t检验,对结果按频次%、PEM(蛋白质能量营养不良)级移、评估参数变化及显著性水平进行分析。结果-两组在Daurabalya(~疲劳)方面都有显著的结果,而Pathadi churna组在Agnimandya(~食欲不振)方面有显著的结果;消化不良),体重,身高体重,BMI, PEM分级,血红蛋白值,血清蛋白和amp;钙。在两组比较中,蛋白粉与白芨粉的差异有统计学意义。结论:两组都在Daurbalya中看到了显著的结果,但相比之下,Pathadi churna组在所有主观和客观标准上都有更显著的效果。本研究未见不良反应报告。进一步采用标准对照的大样本研究将为结果提供更好的证据。
{"title":"A comparative study on the effectiveness of Pathadi churna and Protein powder in Karshya (Undernutrition) among preschool children","authors":"Renu B Rathi, Monali Kurhadkar, Bharat J Rathi, Sandesh Khobragade, Sumod Khedekar","doi":"10.47552/ijam.v14i3.3612","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3612","url":null,"abstract":"Introduction: Ayurveda depicts a disease named ‘Karshya’ which goes hand in hand with the clinical entity ‘Under-nutrition’ in contemporary science. Aim & Objectives: The present study aimed to compare the efficacy of ‘Pathadi churna’ and Protein Powder as oral administration in preschool children suffering from Under-nutrition. Methodology- The trial was a randomized parallel group carried out in 30 children aged 3 to 6 years presenting with the clinical features of under-nutrition who were divided into two groups equally. In Pathadi churna (group A-trial) and protein powder (control, group B), Pathadi churna and protein powder respectively was given in dosage according to age as per Young’s formula for 60 days. Results were analyzed according to frequency %, PEM (protein energy malnutrition) gradation shift, changes in assessment parameters, and the level of significance were noted by using Wilcoxon signed rank test and the Student’s paired t-test. Results- Significant results were noted in Daurabalya (~Fatigue) in both the groups whereas the Pathadi churna group showed significant results in the Agnimandya (~Lack of appetite & poor digestion), weight, weight for height, BMI, PEM gradation, and the values of hemoglobin, serum proteins & calcium. On comparing both groups, statistically significant differences were seen in Pathadi churna than Protein powder. Conclusion- Significant results were seen in Daurbalya in both the groups but on comparison more significant effects were noted for all subjective and objective criteria in the Pathadi churna group. No ADR was reported in the study. Further large sample studies with standard control would render better evidence in results with justification.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Yashtimadhu ghrit matra basti in post-operative management of Ano-rectal Cases – A case Series 亚实替玛陀基础疗法在肛肠术后治疗中的疗效-一个病例系列
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3646
Pavithra Jaivarshaa, Devyani Dasar, Akshay Kumar
Background- Exploitation of analgesics is becoming an advent scenario in the current practice of both medical and surgical cases. Adopting a less complicated and a wholesome beneficial modality for post operative analgesia is the need of the hour. In this case series, focus has been placed on yashti ghrit matra basti as the intervention for pain and wound management of post-operative cases of chronic fissure in ano associated with internal haemorrhoids. Objective- The current study was aimed at post operative analgesia and wound management with yashti ghrit matra basti in ano-rectal cases. Material & Methods-The method adopted here was Lord’s anal dilatation followed by excision of sentinel tags or ligation haemorrhoidectomy according to the case presentation, followed by yashti ghrit mastra basti as primary ayurvedic intervention for post operative analgesia and wound healing. Results -It is found that the planned treatment gave a positive response as post operative analgesia and also played an adjuvant role in wound healing. Conclusion-This case series provides the successful pain and wound management of post-operative ano-rectal cases with a promising ayurvedic intervention.
背景-在当前的医学和外科实践中,镇痛药的使用正在成为一种前景。采用一种简单、健康、有益的方式进行术后镇痛是当前的需要。在本病例系列中,重点是将基底瑜伽术作为慢性肛裂合并内痔术后疼痛和伤口处理的干预措施。目的:本研究的目的是在肛管直肠病例中应用基础雅司提法进行术后镇痛和伤口处理。材料,方法:本研究采用洛德氏肛门扩张术,根据病例介绍,切除前哨标签或结扎痔切除术,再辅以雅诗提基础瑜伽作为主要的阿育吠陀干预,用于术后镇痛和伤口愈合。结果:计划治疗对术后镇痛有积极作用,对创面愈合也有辅助作用。结论:本病例系列提供了成功的疼痛和伤口管理肛肠手术后的情况下,有希望的阿育吠陀干预。
{"title":"Efficacy of Yashtimadhu ghrit matra basti in post-operative management of Ano-rectal Cases – A case Series","authors":"Pavithra Jaivarshaa, Devyani Dasar, Akshay Kumar","doi":"10.47552/ijam.v14i3.3646","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3646","url":null,"abstract":"Background- Exploitation of analgesics is becoming an advent scenario in the current practice of both medical and surgical cases. Adopting a less complicated and a wholesome beneficial modality for post operative analgesia is the need of the hour. In this case series, focus has been placed on yashti ghrit matra basti as the intervention for pain and wound management of post-operative cases of chronic fissure in ano associated with internal haemorrhoids. Objective- The current study was aimed at post operative analgesia and wound management with yashti ghrit matra basti in ano-rectal cases. Material & Methods-The method adopted here was Lord’s anal dilatation followed by excision of sentinel tags or ligation haemorrhoidectomy according to the case presentation, followed by yashti ghrit mastra basti as primary ayurvedic intervention for post operative analgesia and wound healing. Results -It is found that the planned treatment gave a positive response as post operative analgesia and also played an adjuvant role in wound healing. Conclusion-This case series provides the successful pain and wound management of post-operative ano-rectal cases with a promising ayurvedic intervention.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135788424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnozoological survey of Non conventional food items and their therapeutic use by the traditional healers of Dhemaji district of Assam, North-East India 印度东北部阿萨姆邦Dhemaji地区非传统食品及其治疗用途的民族动物学调查
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3959
Mallika Gogoi, Jharna Chakravorty
Assam one of the North Eastern states of India is gifted with diverse natural resources and inhabited by varied ethnic communities. Dhemaji district of Assam is also not exceptional in this regard. A survey was conducted on zootherapeutics among the traditional healers of Dhemaji district through personal interview from 2016 January to 2017 January in fifteen non tribal inhabited villages among 75 respondents of the age group 50-70years. It was documented that the ethnic people of Dhemaji used a total of 26 species of non conventional food items for their therapeutic value against various ailments including itching, burning, asthma, paralysis, weakness etc. These species include varieties of vertebrate and invertebrate species such as arthropods, molluscs, amphibians, aves, reptiles, pisces and mammals depending on their seasonal availability. The highest no of animal species used for the traditional therapeutics is mammals (29%) followed by pisces (19%), arthropoda and reptiles(15%), aves (13%) and the least are amphibia and mollusca (each comprises only 4% species). The study reveals that the ethnic people of Dhemaji are rich in traditional therapeutics and proper documentation and scientific analysis may lead to new drug discovery and conservation of these valuable faunal species.
阿萨姆邦是印度东北部的一个邦,拥有丰富的自然资源,居住着不同的民族社区。阿萨姆邦的德马吉区在这方面也不例外。本研究于2016年1月至2017年1月在15个非部落居住村庄对75名年龄在50-70岁之间的受访者进行了访谈,对Dhemaji地区传统治疗师进行了动物疗法调查。文献记载,Dhemaji少数民族共使用26种非传统食物来治疗各种疾病,包括瘙痒、灼烧、哮喘、麻痹、虚弱等。这些物种包括各种脊椎动物和无脊椎动物,如节肢动物、软体动物、两栖动物、鸟类、爬行动物、双鱼和哺乳动物,这取决于它们的季节性供应。用于传统疗法的动物种类最多的是哺乳动物(29%),其次是双鱼(19%)、节肢动物和爬行动物(15%)、鸟类(13%),最少的是两栖动物和软体动物(每种仅占4%)。研究表明,Dhemaji民族拥有丰富的传统疗法,适当的文献和科学分析可能会导致新药的发现和这些珍贵的动物物种的保护。
{"title":"Ethnozoological survey of Non conventional food items and their therapeutic use by the traditional healers of Dhemaji district of Assam, North-East India","authors":"Mallika Gogoi, Jharna Chakravorty","doi":"10.47552/ijam.v14i3.3959","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3959","url":null,"abstract":"Assam one of the North Eastern states of India is gifted with diverse natural resources and inhabited by varied ethnic communities. Dhemaji district of Assam is also not exceptional in this regard. A survey was conducted on zootherapeutics among the traditional healers of Dhemaji district through personal interview from 2016 January to 2017 January in fifteen non tribal inhabited villages among 75 respondents of the age group 50-70years. It was documented that the ethnic people of Dhemaji used a total of 26 species of non conventional food items for their therapeutic value against various ailments including itching, burning, asthma, paralysis, weakness etc. These species include varieties of vertebrate and invertebrate species such as arthropods, molluscs, amphibians, aves, reptiles, pisces and mammals depending on their seasonal availability. The highest no of animal species used for the traditional therapeutics is mammals (29%) followed by pisces (19%), arthropoda and reptiles(15%), aves (13%) and the least are amphibia and mollusca (each comprises only 4% species). The study reveals that the ethnic people of Dhemaji are rich in traditional therapeutics and proper documentation and scientific analysis may lead to new drug discovery and conservation of these valuable faunal species.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical study of add on effect of Triphaladaruadi Kwatha (Vangsenokta) along with antidiabetic drug in management of Prameha (Non-Insulin Dependent Diabetes mellitus- NIDDM) 三联达联合降糖药治疗非胰岛素依赖型糖尿病(Prameha, NIDDM)的临床研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3744
Abhilasha C Lagad, Vishwas E Gogate, Almas Y Khan, Pooja S Kombe, Pallavi N Mane, None Abhijit Shekhar
Prameha (Diabetes mellitus) is an age long disease known from vedic period and now it is a leading lifestyle disorder. Diabetes mellitus is a group of metabolic syndromes of fat, protein and carbohydrate which is due to absolute or relative deficiency of insulin. The prevalence of diabetes in India has risen from 7.1% in 2009 to 8.9% in 2019.1 The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045.2 In India, it is also 3rd leading cause of death (After heart disease and cancer). The number is projected to be twice by 2030. Type 2 diabetes makes up about 85-90% of all cases. Increase in the overall diabetes prevalence rates largely reflect an increase in risk factors for type 2, notably greater longevity and being overweight or obese. Hence preventive measures are essential and an ideal therapy is still obscure. It remains one of the baffling enigmas for clinical research. This is a randomized single blind standard controlled clinical trial conducted on 66 patients of Prameha (Type II DM & who are on antidiabetic treatment) to rule out Add on effect of Triphaladaruadi kwath of either gender between age group of 40-60 years and grouped into Group A & Group B. 33 patients in group A were on Antidiabetic drug (Metformin 500mg OD/BD and 33 patients in Group B are on same antidiabetic drug (Metformin 500mg OD/BD) with additional Triphaladaruadi kwath (Decoction) for 3 months. Results obtained in subjective and objective parameters were analyzed for the statistical significance by adapting paired ‘t’ test in the groups, Two-way ANOVA test between the groups, and Wilcoxon rank sum test. The study revealed that Group B was found to be more effective in bringing symptomatic relief and improving biochemical markers in the patients of Prameha.
糖尿病是一种从吠陀时期就存在的长期疾病,现在它是一种主要的生活方式疾病。糖尿病是由胰岛素的绝对或相对缺乏引起的一组脂肪、蛋白质和碳水化合物代谢综合征。印度的糖尿病患病率从2009年的7.1%上升到2019年的8.9%。2019年的估计显示,印度有7700万人患有糖尿病,预计到20452年将超过1.34亿人。在印度,糖尿病也是第三大死亡原因(仅次于心脏病和癌症)。预计到2030年,这一数字将增加一倍。2型糖尿病约占所有病例的85-90%。总体糖尿病患病率的增加在很大程度上反映了2型糖尿病风险因素的增加,尤其是寿命延长和超重或肥胖。因此,预防措施是必不可少的,理想的治疗方法仍然模糊不清。它仍然是临床研究中令人困惑的谜之一。这是一项随机单盲标准对照临床试验,对66例Prameha (II型糖尿病)患者进行了研究。年龄在40 ~ 60岁之间的患者,分为A组和A组;B组33例患者给予降糖药(二甲双胍500mg OD/BD)治疗,B组33例患者给予相同降糖药(二甲双胍500mg OD/BD)治疗,加用三甲达伐地汤治疗,疗程3个月。采用组内配对t检验、组间双因素方差分析检验和Wilcoxon秩和检验对主客观参数所得结果进行统计学显著性分析。研究发现,B组对Prameha患者的症状缓解和生化指标改善更为有效。
{"title":"Clinical study of add on effect of Triphaladaruadi Kwatha (Vangsenokta) along with antidiabetic drug in management of Prameha (Non-Insulin Dependent Diabetes mellitus- NIDDM)","authors":"Abhilasha C Lagad, Vishwas E Gogate, Almas Y Khan, Pooja S Kombe, Pallavi N Mane, None Abhijit Shekhar","doi":"10.47552/ijam.v14i3.3744","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3744","url":null,"abstract":"Prameha (Diabetes mellitus) is an age long disease known from vedic period and now it is a leading lifestyle disorder. Diabetes mellitus is a group of metabolic syndromes of fat, protein and carbohydrate which is due to absolute or relative deficiency of insulin. The prevalence of diabetes in India has risen from 7.1% in 2009 to 8.9% in 2019.1 The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045.2 In India, it is also 3rd leading cause of death (After heart disease and cancer). The number is projected to be twice by 2030. Type 2 diabetes makes up about 85-90% of all cases. Increase in the overall diabetes prevalence rates largely reflect an increase in risk factors for type 2, notably greater longevity and being overweight or obese. Hence preventive measures are essential and an ideal therapy is still obscure. It remains one of the baffling enigmas for clinical research. This is a randomized single blind standard controlled clinical trial conducted on 66 patients of Prameha (Type II DM & who are on antidiabetic treatment) to rule out Add on effect of Triphaladaruadi kwath of either gender between age group of 40-60 years and grouped into Group A & Group B. 33 patients in group A were on Antidiabetic drug (Metformin 500mg OD/BD and 33 patients in Group B are on same antidiabetic drug (Metformin 500mg OD/BD) with additional Triphaladaruadi kwath (Decoction) for 3 months. Results obtained in subjective and objective parameters were analyzed for the statistical significance by adapting paired ‘t’ test in the groups, Two-way ANOVA test between the groups, and Wilcoxon rank sum test. The study revealed that Group B was found to be more effective in bringing symptomatic relief and improving biochemical markers in the patients of Prameha.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"94 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Evaluation of Dashamula saindhavaa Sarpi as Nasya (nasal administration) versus Oral administration in the Management of Ardhavabhedaka (~Migraine): A Randomized Parallel Group Clinical Study Dashamula saindhavaa Sarpi作为鼻窦给药与口服给药治疗Ardhavabhedaka(~偏头痛)的比较评价:随机平行组临床研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3391
Gaurav Sinha, Kalpana Patni
Ardhavabhedaka is described as one of the eleven types of Shiroroga (headache disorders) in all Ayurvedic classical texts. It is a disease in which there is acute pain in half of the head, laterals of the neck, temporal region, ear and eyes. Based on the similarity in etiology, pathology, symptoms and treatment principles Ardhavabhedaka can be very well connected with migraine. As per the International Headache Society (IHS), Migraine accounts for 16% of all primary headaches. As per WHO, Migraine prevalence and incidence of the attack suggest that migraine attacks around 3000 persons per million populations every day globally. Aim of Study: To compare the effect of Dashmula saindhavaa Sarpi Nasya and Oral in the Management of Ardhavabhedaka wsr to Migraine. Material and Methods: Total of 68 patients of age group 16 to 60 years of either sex were enrolled based on headache as the chief complaint. After screening via a Pre-diagnostic questionnaire (IHS), 24 patients were excluded and 44 patients recruited were randomly divided into two groups, group A received Dashmula saindhavaa Sarpi nasya, 6 drops in each nostril for 7 days, repeated after intervals of 1 week (four cycles) and Group B received Dashmula saindhava Sarpi orally 12 grams/day in two divided doses for 2 months. The assessment was done based on 4 point grading score of Clinical symptoms of Ardhavabhedaka (Migraine). Result: Overall effect of therapy shows that in Group A 05.00% had the complete cure, 50.00% of patients had marked improvement and 40.00% had moderate improvement whereas, in Group B, 05.88% had the complete cure, 35.29% of patients had marked improvement and 35.29% had moderate improvement. Both groups showed highly significant results (p = >0.001) in severity, duration, and frequency and various parameters of Ardhavabhedaka with more percentage improvement in Group A i.e., with Nasya therapy. Conclusion: Clinical assessment of Dashmula saindhava Sarpi nasya and as oral therapy on different parameters of Ardhavabhedaka showed that both are effective and safe.
在所有阿育吠陀经典文献中,Ardhavabhedaka被描述为11种Shiroroga(头痛疾病)之一。这种疾病的症状是头部的一半、颈部侧面、颞区、耳朵和眼睛都有剧烈疼痛。基于在病因、病理、症状和治疗原理上的相似性,Ardhavabhedaka可以很好地与偏头痛联系起来。根据国际头痛协会(IHS)的数据,偏头痛占所有原发性头痛的16%。根据世卫组织的数据,偏头痛的患病率和发病率表明,全球每天每百万人中约有3000人患有偏头痛。研究目的:比较中药丹参与口服丹参治疗偏头痛的疗效。材料与方法:以头痛为主诉的患者共68例,年龄16 ~ 60岁,男女不限。通过预诊断问卷(IHS)筛选,排除24例患者,纳入44例患者,随机分为两组,a组患者给予Dashmula saindhava Sarpi,每个鼻孔6滴,连续7天,每隔1周重复一次(4个周期);B组患者口服Dashmula saindhava Sarpi 12克/天,分两次服用,连续2个月。根据Ardhavabhedaka(偏头痛)临床症状4分评分进行评估。结果:综合治疗效果:A组患者完全治愈率为05.00%,显著改善率为50.00%,中度改善率为40.00%;B组患者完全治愈率为05.88%,显著改善率为35.29%,中度改善率为35.29%。两组在Ardhavabhedaka的严重程度、持续时间、频率和各种参数方面均显示出高度显著的结果(p = >0.001), A组(即使用Nasya治疗)的改善百分比更高。结论:经临床评价,丹参和丹参作为口服药物治疗丹参的不同参数均有效、安全。
{"title":"Comparative Evaluation of Dashamula saindhavaa Sarpi as Nasya (nasal administration) versus Oral administration in the Management of Ardhavabhedaka (~Migraine): A Randomized Parallel Group Clinical Study","authors":"Gaurav Sinha, Kalpana Patni","doi":"10.47552/ijam.v14i3.3391","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3391","url":null,"abstract":"Ardhavabhedaka is described as one of the eleven types of Shiroroga (headache disorders) in all Ayurvedic classical texts. It is a disease in which there is acute pain in half of the head, laterals of the neck, temporal region, ear and eyes. Based on the similarity in etiology, pathology, symptoms and treatment principles Ardhavabhedaka can be very well connected with migraine. As per the International Headache Society (IHS), Migraine accounts for 16% of all primary headaches. As per WHO, Migraine prevalence and incidence of the attack suggest that migraine attacks around 3000 persons per million populations every day globally. Aim of Study: To compare the effect of Dashmula saindhavaa Sarpi Nasya and Oral in the Management of Ardhavabhedaka wsr to Migraine. Material and Methods: Total of 68 patients of age group 16 to 60 years of either sex were enrolled based on headache as the chief complaint. After screening via a Pre-diagnostic questionnaire (IHS), 24 patients were excluded and 44 patients recruited were randomly divided into two groups, group A received Dashmula saindhavaa Sarpi nasya, 6 drops in each nostril for 7 days, repeated after intervals of 1 week (four cycles) and Group B received Dashmula saindhava Sarpi orally 12 grams/day in two divided doses for 2 months. The assessment was done based on 4 point grading score of Clinical symptoms of Ardhavabhedaka (Migraine). Result: Overall effect of therapy shows that in Group A 05.00% had the complete cure, 50.00% of patients had marked improvement and 40.00% had moderate improvement whereas, in Group B, 05.88% had the complete cure, 35.29% of patients had marked improvement and 35.29% had moderate improvement. Both groups showed highly significant results (p = >0.001) in severity, duration, and frequency and various parameters of Ardhavabhedaka with more percentage improvement in Group A i.e., with Nasya therapy. Conclusion: Clinical assessment of Dashmula saindhava Sarpi nasya and as oral therapy on different parameters of Ardhavabhedaka showed that both are effective and safe.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative Study of Structural Properties and Antacid activity of some commercial samples of Shauktika bhasma 几种商品样品的结构特性和抗酸活性比较研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3808
Mrudula Wadekar, Adsul V B
Backgroud: Shauktika Bhasma is a traditional ayurvedic medicine which is an excellent remedy for a number of stomach disorders, hyper acidity and ulcers. It is prepared from mother pearl by subjecting the powder of mother pearl to traditional ayurvedic processes. To get a worldwide recognition to such supreme ancient medicine, it is necessary to reinvestigate it on the basis of modern analytical techniques.In the present work a comparative study of some commercial samples of Shauktika bhasma is undertaken to understand the current status of this bhasma and to explore its acid neutralization capacity using back titration method. Materials and Methods: Samples from renowned pharmacies are collected and subjected to chemical and structural investigations using analytical techniques like XRD, IR and UV. Back titration method is applied to find acid neutralizing capacity of these bhasma samples. Conclusion:The study reveals that Shauktika bhasma is chemically calcite form of calcium carbonate. Antacid activity of the samples is reported for these samples using simple titration method which is useful to estimate number of moles neutralized for a quick comparison. The antacid activity of the samples is found to be inversely proportional to the crystallite size of the bhasma.
背景:Shauktika Bhasma是一种传统的阿育吠陀药物,对许多胃病,胃酸和溃疡有很好的治疗作用。它是由珍珠母粉经传统的阿育吠陀工艺制备而成。为了使这一至尊古药得到全世界的认可,有必要在现代分析技术的基础上对其进行重新研究。在本工作中,对一些商业样品进行了比较研究,以了解这种bhasma的现状,并利用反滴定法探索其酸中和能力。材料和方法:收集来自知名药店的样品,并使用XRD, IR和UV等分析技术进行化学和结构研究。用反滴定法测定了样品的酸中和能力。结论:研究表明肖提卡火山泥为碳酸钙的方解石形态。用简单的滴定法对这些样品的抗酸活性进行了报道,这有助于估计中和的摩尔数以进行快速比较。发现样品的抗酸活性与基质的晶粒大小成反比。
{"title":"A comparative Study of Structural Properties and Antacid activity of some commercial samples of Shauktika bhasma","authors":"Mrudula Wadekar, Adsul V B","doi":"10.47552/ijam.v14i3.3808","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3808","url":null,"abstract":"Backgroud: Shauktika Bhasma is a traditional ayurvedic medicine which is an excellent remedy for a number of stomach disorders, hyper acidity and ulcers. It is prepared from mother pearl by subjecting the powder of mother pearl to traditional ayurvedic processes. To get a worldwide recognition to such supreme ancient medicine, it is necessary to reinvestigate it on the basis of modern analytical techniques.In the present work a comparative study of some commercial samples of Shauktika bhasma is undertaken to understand the current status of this bhasma and to explore its acid neutralization capacity using back titration method. Materials and Methods: Samples from renowned pharmacies are collected and subjected to chemical and structural investigations using analytical techniques like XRD, IR and UV. Back titration method is applied to find acid neutralizing capacity of these bhasma samples. Conclusion:The study reveals that Shauktika bhasma is chemically calcite form of calcium carbonate. Antacid activity of the samples is reported for these samples using simple titration method which is useful to estimate number of moles neutralized for a quick comparison. The antacid activity of the samples is found to be inversely proportional to the crystallite size of the bhasma.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"98 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparative Pharmaceutical Study of Abhrasindoora by Traditional and Contemporary Method 传统方法与现代方法的比较研究
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-10-03 DOI: 10.47552/ijam.v14i3.3802
Rakesh Bramhankar, Abhaya Kumar Mishra, Nisha Munishwar, Himangshu Baruah, Snigdha Mandal
Background: Rasashastra is a Pharmacotherapeutics of Mercurial, Metallic, and Mineral preparations Abhrasindoora (AS) is a unique Herbo-Metallic-Mineral Compound, which is mainly indicated in respiratory diseases. Method: AS contains Dhanyabhraka (Bio-purified Black Mica Powder), Shodhita Parada (Bio-purified Mercury), and Shodhita Gandhaka (Bio-purified Sulphur) in equal proportion. These mixtures were subjected to trituration in Kharal till Kajjali formation (ABS-72 hrs) followed by impregnation of latex of Arka (Calotropis procera linn) (QS) (16 hrs) and Vatashunga (Ficus benghalensis linn) (QS) (15 hrs). Then Batch-A & Batch-B were prepared separately in Valuka Yantra and Electric Muffle furnace by maintaining mild (150 0C-250 0C), (150 0C - 300 0C) moderate (250 0C -400 0C), (300 0C -450 0C) and intense temperature (400 0C - 550 0C), (450 0C -650 0C) respectively. Observation: Batch A AS was prepared in 37 hours and the total yield of the product obtained was 54 grams. Batch B AS was prepared in 21 hours and the total yield of the product obtained was 25 grams. Jet black colour Kajjali of AS turned to dark red which was sublimated at the neck of Kachkupi. Conclusion: The yield of Batch A was more than Batch B but it took more time. Hence, the preparation of Kupipakva Rasayana in a sand bath should be done repeatedly to conclude it is a more economic and convenient process.
背景:Rasashastra是一种汞、金属和矿物制剂的药物治疗药物,Abhrasindoora (AS)是一种独特的草本金属矿物化合物,主要用于呼吸系统疾病。方法:AS以等比例含有danyabhraka(生物纯化黑云母粉)、Shodhita Parada(生物纯化汞)和Shodhita Gandhaka(生物纯化硫)。这些混合物在卡拉尔发酵至Kajjali形成(ABS-72小时),然后浸渍Arka (Calotropis procera linn) (QS)(16小时)和Vatashunga (Ficus benghalensis linn) (QS)(15小时)的乳胶。然后是批次a;b批分别在Valuka Yantra和电马弗炉中分别保持温和(150℃-250℃)、(150℃- 300℃)、温和(250℃-400℃)、300℃-450℃和高温(400℃- 550℃)、450℃-650℃制备。观察:A批AS的制备时间为37 h,所得产品总得率为54 g。在21小时内制备了B批AS,得到的产品总收率为25克。AS的黑色卡佳莉变成了深红色,在Kachkupi的颈部升华。结论:A批的产率高于B批,但耗时较长。因此,在沙浴中制备Kupipakva Rasayana应反复进行,以得出结论,这是一种更经济、更方便的方法。
{"title":"A Comparative Pharmaceutical Study of Abhrasindoora by Traditional and Contemporary Method","authors":"Rakesh Bramhankar, Abhaya Kumar Mishra, Nisha Munishwar, Himangshu Baruah, Snigdha Mandal","doi":"10.47552/ijam.v14i3.3802","DOIUrl":"https://doi.org/10.47552/ijam.v14i3.3802","url":null,"abstract":"Background: Rasashastra is a Pharmacotherapeutics of Mercurial, Metallic, and Mineral preparations Abhrasindoora (AS) is a unique Herbo-Metallic-Mineral Compound, which is mainly indicated in respiratory diseases. Method: AS contains Dhanyabhraka (Bio-purified Black Mica Powder), Shodhita Parada (Bio-purified Mercury), and Shodhita Gandhaka (Bio-purified Sulphur) in equal proportion. These mixtures were subjected to trituration in Kharal till Kajjali formation (ABS-72 hrs) followed by impregnation of latex of Arka (Calotropis procera linn) (QS) (16 hrs) and Vatashunga (Ficus benghalensis linn) (QS) (15 hrs). Then Batch-A & Batch-B were prepared separately in Valuka Yantra and Electric Muffle furnace by maintaining mild (150 0C-250 0C), (150 0C - 300 0C) moderate (250 0C -400 0C), (300 0C -450 0C) and intense temperature (400 0C - 550 0C), (450 0C -650 0C) respectively. Observation: Batch A AS was prepared in 37 hours and the total yield of the product obtained was 54 grams. Batch B AS was prepared in 21 hours and the total yield of the product obtained was 25 grams. Jet black colour Kajjali of AS turned to dark red which was sublimated at the neck of Kachkupi. Conclusion: The yield of Batch A was more than Batch B but it took more time. Hence, the preparation of Kupipakva Rasayana in a sand bath should be done repeatedly to conclude it is a more economic and convenient process.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135789897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Ayurvedic Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1